Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronedarone vs Amiodarone for Maintenance of Sinus Rhythm in AF
NCT00489736Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 23
01
Overview
Phase 3, randomised, double-blind trial of dronedarone in Atrial fibrillation (AFib) (2 arms), sponsored by Sanofi. Primary endpoint: Treatment Failure at 15 months. Started Jun 2007; status: completed.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00489736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489736.